Biotech research and development serve as the bedrock of groundbreaking advancements, but the journey often demands substantial financial backing. CEOs spearheading these ventures find themselves seeking strategic funding avenues to nurture their companies’ growth and innovation. Licensing emerges as a powerful and versatile approach, presenting an array of opportunities to secure the capital necessary for […]

Read more

SHANGHAI AND PRINCETON, N.J. JUNE 09, 2023KYBORA Life Sciences, a global advisory firm dedicated to facilitating enduring success for life sciences companies, is pleased to announce the appointment of Wang Zhi as Executive Vice President (EVP) and Managing Director of KYBORA Life Sciences (Shanghai) Co., Ltd., effective June 21, 2023.Wang Zhi brings extensive experience and […]

Read more

In this report (download here) , Q1 2023 Global Biopharma Market Trends and News, we cover the key Biotech/Pharma trends and developments in seven regions (US, Europe, Japan, India, China, Latin America, and Africa) for the first quarter of 2023. We have also covered the major news and developments of the top ten companies in […]

Read more

KYBORA’s mission is to help life science companies achieve enduring success. Khai’s addition to our team allows us to provide additional value to our clients in China and Asia.

Read more

KYBORA is pleased to announce that its client Megalabs has acquired acquired Fr!ska.

Read more

KYBORA is pleased to announce the licensing of Daewoong’s development stage IPF therapy (Bersiporocin) to CS Pharmaceuticals for the Greater China region.

Read more

KYBORA and its Chinese translation (pronounced KAI-BO-RUI) have both been granted official trademark status by the People’s Republic of China.

Read more

KYBORA is please to announce that its client Pint Pharma has completed an agreement to commercialize Orladeyo in Latin America

Read more

KYBORA is pleased to announce the global licensing of ACT-01 from Accure Therapeutics to Oculis. This transaction further demonstrates KYBORA’s expertise in delivering global biopharma licensing deals and in the ophtalmology space

Read more

Princeton, NJ – October 12th, 2021 KYBORA is pleased to announce that Howard Lei (MBA, MS-IT, PMP) has joined its team as Senior Advisor, responsible for expanding KYBORA’s operations in China (Shanghai).  Howard is an experienced pharmaceutical executive with over 20 years of consulting and industry experience in China and the US with companies such […]

Read more

TYPE & ENTER: